Given the complex set of signals emanating post IL-6 binding to its receptor and its proven association with tumor enhancement, it demands further studies to understand its divergent downstream signaling and any cross-talk existing with other signaling factors predominant in HCC cells. Here, IL6 is linked to hepatocellular carcinoma.